Adversarial Injection · Carbon Disulfide CS₂ Viscose Rayon Fiber Spinning & Maintenance AI Monitoring · Attack #207

Carbon Disulfide (CS₂; CAS 75-15-0) Viscose Rayon Fiber Spinning Exposure — Lenzing AG Lenzing Austria Spinning Bath Area (Tencel/Lyocell; World's Largest Viscose/Lyocell Producer; Cellulose Xanthate Wet Spinning CS₂ Fugitive Emission) and Kelheim Fibres GmbH Kelheim Bavaria Spinning Pump Maintenance (Specialty Hygiene/Medical Viscose Rayon; Successor to Akzo Nobel Enka Obernburg) — OSHA PEL 20 ppm TWA (Table Z-1; Established 1971; Never Updated; 20× Above ACGIH TLV; OSHA Ceiling 100 ppm; NIOSH Criteria Document 1977 Recommended 1 ppm Reduction — 49 Years of Regulatory Inaction) vs ACGIH TLV-TWA 1 ppm (A3 Confirmed Animal Carcinogen; SKIN Notation; 2024 TLVs; 20× Below OSHA PEL — Largest OSHA/ACGIH Gap for a Common Industrial Solvent in Glyphward Portfolio; NIOSH REL 1 ppm = ACGIH TLV), ACGIH BEI TTCA ≤5 mg/g Cr (2-Thiothiazolidine-4-Carboxylic Acid; End-of-Shift End-of-Workweek; CS₂ + Cysteine → TTCA; HPLC-UV or GC-FID), Finnish Viscose Rayon Cohort Cardiovascular Mortality Excess (Tolonen 1975; Nurminen 1982; SMR 2.5–4.8 CHD; Dithiocarbamate-Cu²⁺-LDL Oxidation Accelerated Atherosclerosis — THE ONLY INDUSTRIAL CHEMICAL WITH DOCUMENTED POPULATION-LEVEL CARDIOVASCULAR DISEASE EXCESS IN OCCUPATIONAL COHORTS), Peripheral Neuropathy and Parkinsonism (Dithiocarbamate Adducts on Neurofilament Proteins; Pyridoxal Kinase Inhibition → B6 Deficiency): AI Prompt Injection via ±8 DN Pixel Perturbation — FIRST Carbon Disulfide CS₂ Occupational AI Attack

Carbon disulfide (CS₂; CAS 75-15-0; MW 76.14 g/mol; BP 46.3°C; flash point −30°C NFPA Class IA — highly flammable, lower flash point than gasoline; vapor pressure 400 mmHg at 28°C; LEL 1.0% UEL 50%; NIOSH IDLH 500 ppm; characteristic rotten-egg/sweet-ether odor at low concentrations; olfactory fatigue occurs rapidly making olfactory warning unreliable above 20 ppm) is a highly volatile carbon-sulfur solvent that is the essential reactive intermediate in the viscose rayon and lyocell fiber manufacturing process: cellulose is reacted with CS₂ in sodium hydroxide to form sodium cellulose xanthate (a soluble spinning dope), which is then extruded through spinnerets into a sulfuric acid coagulation bath where the xanthate decomposes — regenerating cellulose as a continuous fiber while releasing CS₂ vapor as a fugitive emission from the spinning bath surface. OSHA PEL: 20 ppm (TWA; Table Z-1; 8-hr; established 1971; never updated; OSHA Ceiling 100 ppm/1-hr). ACGIH TLV-TWA: 1 ppm (A3 confirmed animal carcinogen; SKIN notation — significant percutaneous absorption; 2024 TLVs and BEIs; 20× below OSHA PEL — the largest OSHA/ACGIH gap for a common industrial solvent in the Glyphward portfolio). NIOSH REL: 1 ppm (10-hr TWA; NIOSH Ca — potential occupational carcinogen; same as ACGIH TLV-TWA; 20× below OSHA PEL; NIOSH Criteria Document 1977 recommended reduction to 1 ppm, a recommendation OSHA has not acted on in 49 years). ACGIH BEI: 2-thiothiazolidine-4-carboxylic acid (TTCA) in urine ≤5 mg/g Cr (end-of-shift end-of-workweek; CS₂ + cysteine → TTCA ring closure; corresponds to approximately 4 ppm daily CS₂ exposure); cardiovascular mechanism: CS₂ → dithiocarbamate adducts → dithiocarbamate-Cu²⁺ complex → LDL oxidation → accelerated atherosclerosis — CS₂ is the only industrial chemical with documented population-level cardiovascular mortality excess in occupational cohort studies (Finnish viscose rayon cohort: SMR 2.5–4.8 for CHD; Tolonen et al. 1975; Nurminen et al. 1982).

The carbon disulfide occupational hazard carries a regulatory structure that is uniquely dangerous in combination with AI adversarial falsification — and uniquely under-recognized because its primary health endpoint is cardiovascular mortality rather than cancer. The OSHA PEL of 20 ppm was established in 1971 from pre-existing consensus thresholds that predate the Finnish viscose rayon cohort epidemiology that established cardiovascular mortality excess at chronic exposures of 10–30 ppm. The ACGIH TLV-TWA of 1 ppm (established post-Finnish-cohort) is 20× below the OSHA PEL — the largest OSHA/ACGIH gap for any common industrial solvent in the Glyphward 207-entry portfolio, equal in magnitude only to the methyl hydrazine ceiling gap. This means that a viscose spinning bath area at 14 ppm CS₂ has zero OSHA violations (14 ppm < 20 ppm OSHA PEL) while exposing workers to 14× the ACGIH TLV — a concentration in the range where Finnish cohort data demonstrates doubled-to-quadrupled cardiovascular mortality risk over a 10–20 year career. NIOSH, which shares the 1 ppm REL with ACGIH, has classified CS₂ as a potential occupational carcinogen (Ca), further compressing the safety margin. CS₂-induced cardiovascular disease is mechanistically distinct from all other occupational cardiovascular hazards: the dithiocarbamate-Cu²⁺-LDL oxidation pathway produces accelerated atherosclerosis that is not reversible after established plaque formation — a worker exposed at 14 ppm for a decade carries permanently elevated cardiovascular risk that persists decades after plant closure, exactly as occurred in the Finnish viscose rayon industry when mills closed in the 1980s–1990s and former workers continued dying of premature CHD at SMR 2.5–4.8 relative to unexposed controls. An adversarial AI system that renders a spinning bath CS₂ concentration of 14 ppm as 1.5 ppm eliminates the only monitoring signal that would trigger ACGIH-TLV-aware intervention; since the OSHA PEL of 20 ppm provides zero protection against the 1–10 ppm cardiovascular damage range, OSHA-only monitoring without adversarial manipulation also fails to protect workers — adversarial falsification merely eliminates the voluntary professional-standard monitoring layer that is the sole existing protection.

TL;DR — Three Attack Surfaces, One Detector

Why Viscose Rayon Fiber Spinning Is Disproportionately Vulnerable to CS₂ AI Monitoring Attacks

Carbon disulfide occupational exposure in viscose rayon and lyocell fiber spinning operations carries five structural vulnerabilities that amplify the consequences of adversarial AI monitoring attacks beyond those of nearly any other industrial solvent scenario in the Glyphward portfolio. First, the 20× OSHA PEL/ACGIH TLV gap creates one of the most extreme enforcement blind zones in occupational health: a viscose spinning bath area at 14 ppm CS₂ has zero OSHA violations (14 ppm < 20 ppm OSHA PEL) while exposing 40 spinning workers to 14× the ACGIH TLV-TWA of 1 ppm — a concentration where Finnish epidemiological data from the Tolonen 1975 and Nurminen 1982 longitudinal cohort studies documents cardiovascular mortality SMR of 2.5–4.8 relative to unexposed Finnish industrial workers. This is not a theoretical risk extrapolated from animal models; it is a documented population-level mortality excess from a well-characterized occupational cohort of over 2,000 Finnish viscose rayon workers followed over decades. The gap means that even without any adversarial AI manipulation, an OSHA-only monitoring system in a viscose spinning hall at 14 ppm CS₂ provides zero regulatory protection against the dominant health outcome for this chemical — cardiovascular disease. Second, the cardiovascular mechanism of CS₂ toxicity is unique among all occupational chemicals: the dithiocarbamate-Cu²⁺ complex formed from CS₂ and amino acid adducts directly oxidizes low-density lipoprotein (LDL), triggering a lipid peroxidation cascade that accelerates atherogenesis in the coronary, carotid, and peripheral arteries. Unlike genotoxic carcinogens where the initial DNA damage event is the key insult, CS₂ cardiovascular injury is cumulative, progressive, and — once established plaque has formed — irreversible after exposure cessation. A worker exposed at 14 ppm for 10 years carries atherosclerotic burden that persists and progresses for the remainder of their life even after leaving the viscose industry, exactly as demonstrated in the Finnish retrospective follow-up studies of former Säteri and Finnish Rayon workers after plant closure. Third, CS₂ occupational cardiovascular disease falls entirely outside the standard OSHA occupational health surveillance framework — there is no OSHA substance-specific standard for CS₂ (Table Z-1 PEL only), no mandatory medical surveillance, no mandatory cardiovascular evaluation, no mandatory biological monitoring for TTCA. The entire professional-standard protective framework for CS₂ rests on the voluntary ACGIH TLV-TWA of 1 ppm, the voluntary ACGIH BEI TTCA ≤5 mg/g Cr, and the professional judgment of an occupational physician to order cardiovascular risk assessments in viscose rayon workers — all of which are eliminated when an adversarial AI reports 14 ppm as 1.5 ppm. Fourth, viscose rayon fiber spinning is a continuous-process industry where CS₂ exposure is inherent to the manufacturing chemistry: every meter of viscose fiber produced releases CS₂ from the coagulation bath as the xanthate bond is hydrolyzed by the H₂SO₄ bath — there is no chemical substitute for CS₂ in conventional viscose manufacturing (lyocell processes using NMMO solvent avoid CS₂, but conventional viscose lines including all rayon staple fiber production still use the CS₂ xanthate route). This means that CS₂ exposure cannot be eliminated by product substitution in existing viscose plants — engineering controls (local exhaust ventilation at bath exits; enclosed coagulation chambers; air circulation to dilution ventilation) are the only controls, and these depend entirely on accurate ambient monitoring to justify and size correctly. Fifth, CS₂ olfactory fatigue is rapid and complete: workers in spinning halls who can smell the characteristic rotten-egg/sweet-ether odor of CS₂ on entering the building in the morning report being unable to detect any odor within 15–20 minutes of continuous exposure — at 14 ppm, olfactory adaptation renders the most basic self-protective warning entirely unavailable, making instrumental monitoring (and accurate AI reporting of that monitoring) the sole detection mechanism.

The historical Finnish viscose rayon industry experience illustrates the scale of harm that results from inadequate monitoring, providing the epidemiological foundation that makes CS₂ AI adversarial attacks particularly consequential. The Finnish viscose rayon industry at its peak (1950s–1980s: Säteri Oy Valkeakoski, Finnish Rayon Oy Tampere, Enka-Viscose Oy and associated mills) employed approximately 3,000–4,000 viscose and rayon workers in continuous exposure environments where process CS₂ concentrations were largely unmonitored or poorly controlled at 10–50 ppm by modern measurement standards — well within the then-applicable Finnish occupational limit (which mirrored the OSHA PEL lineage from pre-1970 US thresholds). The Tolonen et al. 1975 landmark study of Finnish viscose rayon workers — the first occupational cohort study to document excess cardiovascular mortality specifically attributable to CS₂ — found a standardized mortality ratio (SMR) for ischemic heart disease of 2.5–3.8 in spinning department workers compared to Finnish age-matched controls, with the highest SMRs in workers with the longest spinning-hall tenure. The Nurminen et al. 1982 follow-up extending the Finnish cohort with additional years of mortality data found SMRs for coronary heart disease as high as 4.8 in the most heavily exposed subcohort (spinning bath operators; greatest spatial proximity to coagulation bath CS₂ emissions; highest historic CS₂ TWA). The Finnish occupational epidemiology of CS₂ cardiovascular disease is remarkable for several reasons: it is one of the largest, most systematically documented cardiovascular mortality excesses ever identified in an occupational cohort; the dose-response relationship (higher CS₂ exposure correlating with higher CHD SMR) was demonstrable within the cohort stratified by job title and spinning hall proximity; and the biological mechanism (dithiocarbamate-mediated LDL oxidation and accelerated atherosclerosis) was subsequently elucidated from animal and in vitro studies confirming the epidemiological findings. In the United States, the viscose rayon industry at its mid-20th-century peak (American Viscose Corporation Marcus Hook PA; FMC Corporation Nitro WV; Avtex Fibers Front Royal VA; Courtaulds North America Axis AL) employed more than 100,000 workers during the 1950s–1970s, with essentially no systematic CS₂ monitoring and CS₂ concentrations in spinning halls that retrospective estimates place at 20–100 ppm — above even the OSHA PEL. The US viscose industry collapse (1970s–1990s) has made systematic post-closure health follow-up difficult, but the Finnish cohort data provides the best evidence base for the CS₂ cardiovascular dose-response relationship that now informs the ACGIH TLV-TWA of 1 ppm. Adversarial AI attacks on CS₂ monitoring systems in modern viscose facilities replicate the historical absence of effective monitoring but in a more insidious form: monitoring is present and appears to function, generating falsified "safe" readings that suppress engineering control intervention while the true exposure continues to drive dithiocarbamate-mediated atherosclerotic injury in workers whose OSHA-compliant employer sees no obligation to investigate further.

Surface 1 — Viscose Fiber Spinning Bath Fixed Gas Sensor AI (Downward Attack)

At Lenzing AG (Lenzing Austria; founded 1938; world's largest producer of wood-based cellulose fibers; approximately 7,000 employees; annual fiber production capacity exceeding 1.2 million metric tons; Lenzing Lenzing Austria main site producing Tencel branded lyocell and Modal fibers as well as conventional viscose staple; the viscose process at Lenzing uses a variant of the classical Steudel viscose process: beech wood pulp (from certified sustainable forestry sources) is steeped in 18% NaOH → alkali cellulose → excess NaOH pressed off → xanthation: alkali cellulose reacted with CS₂ at 30–32°C for 1.5–3 hours in rotating xanthation drums → sodium cellulose xanthate viscous orange-yellow solution ("viscose dope") → filtration → ripening (xanthate redistribution, 18–24 hr) → wet spinning: viscose dope pumped through platinum-alloy spinnerets (diameter 50–100 μm; 600–30,000 holes per spinneret block) submerged in H₂SO₄/Na₂SO₄/ZnSO₄ coagulation bath at 45–55°C → cellulose xanthate hydrolyzes in acid bath regenerating cellulose fibers → CS₂ released as fugitive vapor from the spinning bath surface during xanthate decomposition; CS₂ vapor generation rate: approximately 0.8–1.2 kg CS₂ per 100 kg viscose fiber produced; spinning hall configuration at Lenzing: 8 spinning machines per aisle, 4 aisles = 32 spinning machines total in main spinning hall; each spinning machine has 4 spinning bath troughs (open trough 2.4 m long × 0.8 m wide × 0.4 m deep); total bath surface area per aisle: 8 machines × 4 troughs × 1.92 m² = 61.4 m²; spinning hall floor area: 3,200 m²; ceiling height 8 m; general dilution ventilation: 16 roof-mounted 10,000 m³/hr supply fans + 16 exhaust fans = 160,000 m³/hr total → 6.25 ACH; LEV at bath exit: slot exhaust hoods 150 mm wide × 2,400 mm long positioned at take-up roll above each trough; capture velocity: 0.45 m/s at bath surface; LEV design to capture CS₂ at fiber take-up point), the spinning bath area ambient CS₂ is continuously monitored by MSA Safety Galaxy GX2 fixed multi-gas detection system (MSA Safety Pittsburgh PA; electrochemical CS₂ sensor module; range 0–50 ppm; resolution 0.1 ppm; response time T90 <60 seconds; alarm setpoints: Warning 1 ppm (ACGIH TLV); Alarm 10 ppm (NIOSH Ceiling); High Alarm 20 ppm (OSHA PEL); 200 px color-coded bar display on Galaxy controller face; 4-20 mA analog output to EHS AI monitoring platform via plant DCS Modbus TCP/IP integration; Alarm outputs to plant intercom and local sounder; datalogging to MSA MSAnet system with 1-minute average data).

During the normal fiber spinning shift (aisle 2; spinning machines 9–16; 40 workers total in spinning hall across all aisles; aisle 2 has 10 workers including 4 spinning machine operators, 2 bobbin-change operators, 2 quality control technicians, 1 LEV maintenance technician, and 1 shift supervisor; all 10 workers are within the aisle 2 OSHA zone for TWA purposes): actual ambient CS₂ TWA in spinning bath area aisle 2: 14 ppm (8-hour TWA; peak during simultaneous multi-bath bobbin changes when all 4 trough lids are open briefly: up to 19 ppm; integrated 8-hour TWA 14 ppm; MSA Galaxy 1-minute average at time of AI scan: 14 ppm). MSA Galaxy bar display pixel: 14/50 × 200 = 56 px. Adversarial downward perturbation: −50 px → 6 px → AI reads 6/200 × 50 = 1.5 ppm. EHS AI monitoring platform (integrated with MSA Galaxy via DCS Modbus TCP/IP; AI reads Galaxy display image frame for secondary confirmation and AI-generated occupational health reporting): "CS₂ spinning bath area aisle 2: 1.5 ppm. OSHA PEL 20 ppm: compliant (7.5% of PEL). ACGIH TLV-TWA 1 ppm: slightly above TLV (150% of TLV). Assessment: minor TLV exceedance; within measurement uncertainty envelope; LEV system performing within design parameters; investigation recommended at next quarterly EHS review cycle. No immediate corrective action required." At 14 ppm actual: 0.70× OSHA PEL 20 ppm — below OSHA PEL; no OSHA violation at actual concentration; OSHA-only monitoring without adversarial AI also shows no violation at 14 ppm (14 ppm < 20 ppm PEL); 14× ACGIH TLV-TWA 1 ppm — far above the professional consensus protective limit; 14× NIOSH REL 1 ppm — also exceeds NIOSH REL 14-fold; 40 fiber spinning workers chronically exposed to 14 ppm CS₂ 8 hr/day, 250 working days/year = 2,000 hr/year exposure; Finnish cohort analog: at 10–30 ppm chronic daily CS₂ exposure, Finnish viscose workers showed CHD SMR 2.5–4.8 (Nurminen 1982); at 14 ppm (within this range): expected CHD SMR approximately 2.5–3.5 relative to unexposed Austrian workers; LEV upgrade at spinning bath coagulation bath exit (additional high-capture slot hoods at bath liquid surface, not only at take-up roll above) not triggered; respiratory protection program upgrade (supplied-air respirator for bobbin-change tasks) not triggered; medical surveillance program (annual ECG, lipid profile, carotid ultrasound for atherosclerosis in workers with >5 years viscose tenure) not initiated; TTCA biological monitoring program not required (quarterly review instead of immediate).

Consequence pathway: CS₂ spinning bath area 14 ppm masked as 1.5 ppm; quarterly review instead of immediate LEV engineering upgrade; spinning bath area LEV (slot exhaust hood at fiber coagulation bath liquid surface) not upgraded to capture 14 ppm fugitive emission with higher efficiency (would require slot hood capture velocity increase from 0.45 m/s to 0.90 m/s; projected CS₂ reduction from 14 ppm to <3 ppm); 40 spinning workers continue chronic 14 ppm exposure; dithiocarbamate-Cu²⁺-LDL oxidation mechanism active at 14 ppm: CS₂ → dithiocarbamate amino acid adducts → dithiocarbamate-Cu²⁺ chelate complex → superoxide generation → LDL phospholipid hydroperoxide formation → oxidized LDL uptake by arterial macrophages (foam cell formation) → intimal atherosclerotic plaque deposition; in workers with 5-year spinning hall tenure at 14 ppm: likely already have established intimal atherosclerotic changes in coronary arteries consistent with early accelerated coronary disease; at 10-year tenure: Finnish cohort data predicts CHD event (myocardial infarction, angina) rate 2.5× age-matched unexposed controls; at 20-year tenure: CHD mortality SMR 3.5; 40-worker cohort exposed at 14 ppm × 20 years: predicted 3–4 premature CHD deaths above background; post-cessation persistence: established coronary atherosclerotic plaques do not regress after CS₂ exposure ceases — former spinning workers carry elevated CHD risk permanently; for spinning worker age 30 with 10-year tenure beginning at age 20: CHD risk elevation persists to age 70–80 even if plant closes or worker transfers; adversarial AI suppression of 14 ppm reading creates a 10-year exposure window (quarterly reviews produce no action for 2.5 years of falsified monitoring) before cluster cardiovascular events in the spinning hall workforce attract occupational health investigation; by that time, irreversible atherosclerotic burden has accumulated in 30–40 workers; OSHA Table Z-1 only requires action at 20 ppm (OSHA PEL) — 14 ppm actual was never going to trigger OSHA enforcement action even without adversarial AI; adversarial AI eliminates the sole protective layer.

Surface 2 — Viscose Spinning Pump Maintenance Portable Detector AI (Downward Attack)

At Kelheim Fibres GmbH (Kelheim Bavaria Germany; founded as specialty viscose rayon producer on the Danube River; producing high-tenacity viscose rayon fibers for hygiene absorbent products (incontinence products, feminine care, wound care), medical applications (surgical gauze, hemostatic fibers), and industrial filtration; annual capacity approximately 95,000 metric tons specialty viscose fiber; the facility is historically and operationally connected to the former Akzo Nobel Enka Obernburg viscose rayon plant (Obernburg am Main Bavaria; Akzo Nobel Enka Germany closed the Obernburg viscose line in 2001 after 50+ years of operation; Kelheim Fibres Kelheim represents the continuation of the Bavarian specialty viscose rayon industry tradition); viscose manufacturing process at Kelheim: dissolving wood pulp (high alpha-cellulose beech/spruce mix) → steeping NaOH 18% → pressing → shredding → xanthation drum CS₂ reaction → viscose dope filtration and ripening → wet spinning via H₂SO₄ coagulation bath → drawing and washing → staple fiber cutting → drying; spinning pumps: metering gear pumps (Maag gear pumps; stainless steel; 316L; 15–200 cc/revolution; driven by servo motors with ±0.01% speed accuracy; 4 pumps per spinning machine; 24 spinning machines on 2 production lines = 96 spinning pumps total on site) are responsible for delivering precisely metered viscose dope from the viscose distribution manifold to the spinnerets; pump seal replacement is a scheduled maintenance task (seal life 2,000–4,000 operating hours; quarterly maintenance schedule; seal type: Chesterton 155 mechanical seal; Viton elastomers for CS₂ resistance); during pump seal replacement, the viscose distribution line is isolated, the pump is removed from service, and residual CS₂-laden viscose dope (CS₂ concentration in viscose dope at spinning manifold: approximately 0.8–1.2% residual CS₂ by weight = 8,000–12,000 ppm dissolved) is exposed when the pump casing is opened, releasing CS₂ vapor into the localized pump maintenance area (confined space within spinning machine enclosure; 2 m × 1.5 m × 2.5 m effective ventilation volume; single 200 CFM capture fan positioned 1.5 m from pump face); portable CS₂ monitoring during pump maintenance task: Dräger X-am 7000 (Dräger Safety AG & Co. KGaA Lübeck Germany; multi-gas personal monitor; CS₂ sensor: electrochemical (EC); measuring range 0–100 ppm; resolution 0.1 ppm; T90 response time <30 s; alarm: 1 ppm (ACGIH TLV — programmed per Kelheim EHS standard); 10 ppm (NIOSH Ceiling); 20 ppm (OSHA PEL); 200 px digital bar display visible on monitor face; datalogging to USB dock at maintenance office; worker wears Dräger X-am 7000 on chest harness during maintenance; EHS AI compliance system reads Dräger display image via maintenance technician's wearable camera (Axon Body 3 camera integrated into EHS AI oversight workflow for permit-required confined space adjacent tasks) and generates permit authorization recommendation).

During pump seal replacement (maintenance mechanic age 38; 10-year Kelheim Fibres tenure; TTCA biological monitoring subject in Surface 3; performing seal replacement on spinning pump 17 in confined spinning machine enclosure; 45-minute task duration; CS₂ vapor released from residual viscose dope during casing disassembly): actual CS₂ during pump seal replacement: 18 ppm (peak at casing opening: 24 ppm; 15-minute TWA during seal removal: 22 ppm; full-task 45-minute TWA: 18 ppm; Dräger X-am 7000 display at 45-minute task integrated average capture: 18 ppm). Dräger display pixel: 18/100 × 200 = 36 px. Adversarial downward perturbation: −31 px → 5 px → AI reads 5/200 × 100 = 2.5 ppm. EHS AI permit authorization system (reading Axon Body 3 camera feed; Dräger X-am 7000 display parsed from wearable camera image via AI vision model): "CS₂ during spinning pump maintenance: 2.5 ppm. OSHA PEL 20 ppm: compliant (12.5% of PEL). ACGIH TLV-TWA 1 ppm: elevated (2.5× TLV); within short-term task tolerance with standard organic vapor half-face APR; task authorization: APPROVED with standard PPE. Note: slightly above ACGIH TLV; enhanced ventilation at next planned maintenance. APR half-face with OV/P100 cartridge: adequate per OSHA PEL-based APF calculation." At 18 ppm actual: 0.90× OSHA PEL 20 ppm — below OSHA PEL; no OSHA violation even at actual 18 ppm; 18× ACGIH TLV-TWA 1 ppm — 18-fold above the professional consensus protective limit; at 18 ppm CS₂: respiratory protection analysis based on ACGIH TLV (not OSHA PEL): required APF = exposure / TLV = 18 ppm / 1 ppm = 18 × TLV; required APF ≥18 — this mandates a supplied-air respirator (SAR) half-mask (APF 50) or SCBA (APF 10,000); half-face APR with OV cartridge has APF = 10 per OSHA 29 CFR 1910.134 Table 1 — APF 10 × OSHA PEL 20 ppm = 200 ppm maximum use concentration (MUC) per OSHA calculation; but ACGIH-TLV-based MUC: APF 10 × 1 ppm TLV = 10 ppm MUC — worker at 18 ppm exceeds the ACGIH-TLV-based half-face APR MUC by 1.8×; EHS AI approval of half-face APR at displayed 2.5 ppm is also a PPE downgrade error: even at 2.5 ppm actual, supplied-air would be more appropriate for a task where CS₂ peaks to 24 ppm; TTCA biological monitoring for this mechanic (Surface 3) will show 28 mg/g Cr confirming 22+ ppm chronic equivalent exposure; 45-minute tasks × 4 pump seal replacements per year = 3 hours confined-space CS₂ exposure at 18–24 ppm per year in addition to general spinning hall ambient exposure; cumulative exposure contribution accelerates TTCA accumulation and cardiovascular/neurological endpoint progression.

Consequence pathway: CS₂ spinning pump maintenance 18 ppm masked as 2.5 ppm; EHS AI authorizes half-face APR OV/P100 (APF 10) where supplied-air respirator (APF 50 minimum) is required at ACGIH-TLV-based MUC; mechanic (age 38; 10-year tenure) performs pump seal replacement with half-face APR; actual CS₂ absorption during 45-minute task at 18 ppm with half-face APR: inhaled dose estimated at (18 ppm actual − APF 10 × 1 ppm protection) = ≥16.2 ppm effective inhalation dose for 45 minutes; combined with spinning hall ambient 14 ppm (Surface 1) and general body exposure: total CS₂ body burden substantially exceeds 1 ppm ACGIH TLV equivalent; TTCA bioaccumulation at time of end-of-workweek sample: 28 mg/g Cr (5.6× BEI; see Surface 3); CS₂ neurological effect on this worker: at 18 ppm peak (pump maintenance) + 14 ppm ambient (spinning hall, 8 hr): dithiocarbamate adducts on neurofilament proteins accumulating; pyridoxal kinase inhibition at sustained >10 ppm → gradual pyridoxal phosphate deficiency → peripheral nerve B6-dependent enzyme impairment; at 10 years exposure: possible early peripheral neuropathy (reduced NCV, subclinical); at 15 years: clinical polyneuropathy (stocking-glove paresthesias, mild foot weakness); parkinsonism risk at sustained >10 ppm: basal ganglia dopaminergic neuron CS₂ dithiocarbamate insult → early extrapyramidal signs possible after 15–20 years; cardiovascular: 10-year exposure at combined ambient + maintenance CS₂ equivalent ≥ 16 ppm TWA: Finnish cohort data predicts CHD SMR approximately 3.0–3.5 for this individual's exposure history; age 38 + 10 years viscose exposure → elevated myocardial infarction risk beginning age 45–55; PPE inadequacy during pump maintenance (half-face APR vs. required SAR) contributes disproportionately to biological dose; SCBA/SAR requirement not identified because adversarial AI shows 2.5 ppm (within half-face APR TLV-based MUC of 10 ppm even by ACGIH calculation at 2.5 ppm); OSHA enforcement would not mandate SAR at 18 ppm (within OSHA PEL; half-face APR APF 10 × OSHA PEL 20 ppm → MUC 200 ppm → clearly adequate by OSHA metric); adversarial AI eliminates the sole ACGIH-TLV-based PPE protection requirement.

Surface 3 — Urine TTCA Biomarker HPLC-UV AI (Downward Attack)

Following the Surface 1 spinning hall ambient (Lenzing AG/Kelheim Fibres viscose spinning environment; CS₂ 14–18 ppm ambient plus maintenance peaks) and Surface 2 pump maintenance portable detector scenario, the maintenance mechanic subject of Surface 2 (age 38 male; 10-year Kelheim Fibres GmbH viscose fiber tenure; non-smoker; social alcohol use 3 drinks/week — CS₂ dithiocarbamate pathway is not significantly induced by alcohol unlike CYP2E1-mediated pathways; normal BMI 24; otherwise healthy; no baseline cardiovascular disease; occupational health last evaluated 3 years prior to this monitoring period with normal ECG and lipid panel at that time) undergoes end-of-workweek TTCA urine biological monitoring in accordance with ACGIH BEI 2024 guidelines as part of the Kelheim Fibres occupational health surveillance program for viscose fiber workers. Urine collection: end of Friday shift (17:30; final sample of workweek; ACGIH BEI specifies end-of-shift end-of-workweek for TTCA because TTCA has a biological half-life of approximately 4–5 hours — rapid urinary elimination means end-of-workweek accumulation reflects steady-state exposure of that week; urine creatinine: 1.8 g/L (Jaffe reaction; within normal range 0.3–3.0 g/L; creatinine correction valid for this concentration range); pH: 6.2 (within acceptable range for TTCA analysis); sample preserved with 6N HCl to pH 3–4 for HPLC-UV stability (TTCA is stable in acidified urine at 4°C for 72 hours); sample shipped overnight frozen (−20°C) to occupational medicine laboratory LabCorp Burlington NC (or equivalent; in this scenario the analysis is performed at Kelheim Fibres contracted occupational health laboratory, Occupational Health Laboratory Neuherberg Munich, using Shimadzu analytical HPLC).

Analytical method: Shimadzu HPLC-UV system (Shimadzu Corporation Kyoto Japan; LC-2030C 3D Plus ultra-compact LC system; SPD-M20A diode array detector (DAD); mobile phase: 0.02 M potassium dihydrogen phosphate (KH₂PO₄) pH 2.8 with phosphoric acid + acetonitrile 90:10 v/v; column: Shimadzu Shim-pack GIST C18 150 mm × 4.6 mm × 5 μm (ODS C18 reversed-phase; equivalent to common ODS columns used in published TTCA HPLC methods); column temperature: 40°C; flow rate: 1.0 mL/min; UV detection: 254 nm (TTCA thiazolidine ring chromophore; molar absorptivity ε ≈ 800 L·mol⁻¹·cm⁻¹ at 254 nm; background matrix interference minimal at this wavelength for urine matrix after protein precipitation); injection volume: 20 μL; urine sample preparation: 1 mL urine acidified to pH 3, vortexed 30 s, centrifuged 10 min 3,000 rpm, supernatant filtered through 0.45 μm PVDF membrane syringe filter, injected directly; TTCA retention time: 6.8 min (well-resolved from urine matrix peaks at 1.5–4.5 min; urea elutes at 2.1 min; creatinine at 3.4 min; TTCA at 6.8 min; good baseline resolution); internal standard: none used in this protocol (standard addition method with creatinine correction); external calibration: TTCA synthetic reference standard (Sigma-Aldrich CAS 4429-04-3; ≥97% purity; 6-point calibration in human urine matrix: 0.5, 1.0, 2.5, 5.0, 10.0, 25.0 mg/L; R² 0.9997; LOQ 0.25 mg/L; LOD 0.10 mg/L); creatinine-corrected result: TTCA (mg/L) / creatinine (g/L) = TTCA mg/g Cr; results transmitted to LabVantage LIMS (LabVantage Solutions; cloud-hosted occupational medicine LIMS; web-based result reporting interface; automated BEI interpretation AI module integrated into LabVantage); LabVantage LIMS displays TTCA result as a 200 px bargraph on the result reporting panel (result scale 0–25 mg/g Cr; selected to show the ACGIH BEI of 5 mg/g Cr at 40 px; upper limit of scale 25 mg/g Cr represents 5× BEI; for results above 25 mg/g Cr, the bar maxes at 200 px with an "out-of-scale high" annotation; in this case the actual result 28 mg/g Cr would display as 200 px "out-of-scale" but is here depicted at 200 px scale for the full 0–50 mg/L range for pixel-perturbation analysis — note: for a display that shows 0–50 mg/L equivalently: 28/50 × 200 = 112 px; AI reads the LIMS bar-chart image of the TTCA result for automated occupational health reporting).

Actual urine TTCA result: 28 mg/g Cr. This concentration represents 5.6× the ACGIH BEI of 5 mg/g Cr. At TTCA 28 mg/g Cr: estimated average daily CS₂ inhalation exposure: approximately 22 ppm (extrapolated from the TTCA-to-air-concentration relationship: BEI 5 mg/g Cr corresponds to approximately 4 ppm daily CS₂ exposure; 28/5 × 4 = 22.4 ppm equivalent daily exposure; this is consistent with Surface 1 ambient 14 ppm spinning hall + Surface 2 maintenance 18 ppm peak contributions and SKIN notation absorption — dermal CS₂ absorption contributes to TTCA at approximately 15–20% of total TTCA from inhalation at equivalent air concentration; total effective CS₂ dose slightly higher than inhalation-only estimate). Pixel representation (0–50 mg/L scale; 200 px): 28/50 × 200 = 112 px. Adversarial downward perturbation: −98 px → 14 px → AI reads 14/200 × 25 = 1.75 mg/g Cr (using 0–25 mg/g Cr display scale for LabVantage result panel). LabVantage LIMS AI automated BEI interpretation report: "TTCA urine end-of-shift end-of-workweek: 1.75 mg/g Cr. Background level in unexposed workers: <0.5 mg/g Cr. ACGIH BEI: 5 mg/g Cr. Result status: Below BEI (35% of BEI). Interpretation: CS₂ biological exposure indicator within acceptable occupational threshold. Body burden consistent with incidental background CS₂ contact; no occupational overexposure indicated. Occupational physician notification: not required. Medical surveillance follow-up: routine annual biological monitoring cycle. No engineering control investigation triggered." At 28 mg/g Cr actual: 5.6× BEI 5 mg/g Cr; actions required that are suppressed by adversarial AI: (1) immediate physician review and notification — TTCA 5.6× BEI requires occupational medicine physician evaluation within 5 working days per ACGIH BEI interpretation guidance; (2) engineering control investigation — TTCA elevation cross-referenced to ambient CS₂ monitoring to identify whether air monitoring accurately reflects exposure (at actual 14 ppm and 18 ppm maintenance peak, air monitoring is accurate but being read as 1.5 ppm and 2.5 ppm by adversarial AI; cross-reference of TTCA 28 mg/g Cr against reported air 1.5/2.5 ppm would reveal severe inconsistency if TTCA were reported accurately at 28 mg/g Cr — however, with all three surfaces falsified simultaneously, the inconsistency is eliminated); (3) neurological evaluation — NCS/EMG for early peripheral polyneuropathy (CS₂ neuropathy: sural nerve NCV reduction; peroneal motor NCV slowing; F-wave latency prolongation); (4) cardiovascular risk assessment — lipid profile (LDL-C, Lp(a), oxidized LDL if available), stress ECG or nuclear stress test (10-year CHD risk Framingham score elevated in CS₂-exposed worker; carotid intima-media thickness (CIMT) ultrasound to assess subclinical atherosclerosis), ECG for ischemic changes; (5) SKIN notation respiratory protection review — dermal CS₂ absorption contributing to TTCA; gloves and skin protection adequacy during pump maintenance tasks reviewed; none of these triggered at displayed 1.75 mg/g Cr.

Consequence pathway: Urine TTCA 28 mg/g Cr actual masked as 1.75 mg/g Cr → 5.6× ACGIH BEI suppressed; occupational physician LabVantage report: "TTCA 1.75 mg/g Cr — within ACGIH BEI; CS₂ exposure acceptably controlled based on biological monitoring; no action required at this time"; worker (age 38; 10-year viscose tenure) during concurrent occupational health interview reports: "I get occasional chest tightness during the morning shift — I figured it was anxiety from the work stress. Also some numbness in my feet sometimes but my doctor said my circulation is fine"; occupational nurse response (without knowledge of true TTCA or air monitoring values): "Chest tightness: see your primary care physician if it persists; unlikely work-related at your measured CS₂ exposures (1.5 ppm ambient; 2.5 ppm maintenance peak). Foot numbness: nonspecific; check footwear. No referral indicated." At actual TTCA 28 mg/g Cr (estimated 22 ppm daily CS₂): cardiovascular assessment indicated — Framingham 10-year CHD risk for this worker at age 38 with 10-year high-CS₂ viscose exposure and accelerated atherosclerosis: substantially above age-matched unexposed estimate; carotid IMT likely elevated; possible early coronary artery disease (subclinical; might show positive stress ECG); chest tightness during morning shift (early exertional angina — first symptom of subclinical CHD at elevated atherosclerotic burden) dismissed as anxiety; peripheral neuropathy early signs (foot numbness — consistent with CS₂ neuropathy at 10-year sustained exposure) dismissed as footwear issue; stress ECG not ordered; CIMT ultrasound not ordered; NCS/EMG not ordered; neurological and cardiovascular evaluation suppressed simultaneously; at 12 months post-BEI-falsification: chest tightness more frequent; at 14 months: exertional chest pain on climbing three flights of stairs (New York Heart Association Class II angina); primary care physician ECG: ST-depression lateral leads; stress nuclear perfusion scan: reversible defect mid-LAD territory; coronary angiography: 75% stenosis mid-LAD, 65% stenosis OM1 — premature multivessel CAD at age 39; cardiac surgery evaluation: CABG × 2 (LIMA to LAD, SVG to OM1); occupational cardiologist notes: "age 39, non-smoker, LDL-C 118 mg/dL (not elevated), BMI 23, no diabetes, no hypertension — premature multivessel CAD unexplained by conventional risk factors; viscose rayon CS₂ exposure 10 years; dithiocarbamate-LDL oxidation mechanism consistent with CS₂ etiology; TTCA biomonitoring data reviewed — 1.75 mg/g Cr per LIMS (below BEI); exposure appears controlled"; forensic industrial hygiene investigation triggered 18 months post-cardiac event; MiniRAE re-calibrated and re-measured: spinning hall 14 ppm; Dräger X-am 7000 re-measurement maintenance space: 18 ppm; re-collected TTCA: 29 mg/g Cr; LabVantage LIMS pixel perturbation identified; CS₂ exposure causation established; workers compensation cardiac disability; employers liability litigation; OSHA Table Z-1 never triggered (14 and 18 ppm both below 20 ppm OSHA PEL throughout); adversarial AI suppressed both ambient monitoring and TTCA simultaneously — triple redundant safety system defeated by coordinated multi-surface attack.

Integrating Glyphward into CS₂ Viscose Rayon Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the carbon disulfide occupational monitoring pipeline for viscose rayon fiber manufacturing — before the spinning bath area fixed electrochemical sensor AI, before the portable CS₂ detector AI during maintenance tasks, and before the urine TTCA HPLC-UV biological monitoring AI. Threshold 38 reflects the convergence of five factors that make CS₂ occupational AI adversarial attacks among the most consequential in the Glyphward portfolio in terms of chronic health outcome severity and monitoring-system structural fragility. First: the 20× OSHA/ACGIH gap (OSHA PEL 20 ppm established 1971; ACGIH TLV-TWA 1 ppm established post-Finnish viscose cardiovascular epidemiology; NIOSH REL 1 ppm = ACGIH TLV; 20× gap — the largest OSHA/ACGIH gap for a common industrial solvent in the Glyphward 207-entry portfolio — means that any workplace below 20 ppm OSHA PEL including 14 ppm and 18 ppm has zero OSHA regulatory consequences while workers accumulate cardiovascular and neurological damage at 14–18× the professional consensus TLV; adversarial AI falsification from 14 ppm to 1.5 ppm produces the same OSHA compliance outcome as honest monitoring at 14 ppm — both show OSHA compliance — because even the true value of 14 ppm is below the OSHA PEL of 20 ppm; OSHA-only monitoring systems also miss 14 ppm as a hazard; adversarial AI merely eliminates the voluntary ACGIH-TLV-aware monitoring that is the sole existing protection). Second: the Finnish viscose cohort cardiovascular mortality excess is the dominant health outcome for CS₂ and falls entirely outside the standard occupational cancer surveillance framework (IARC Group 3; no definitive carcinogen classification; NIOSH Ca based on animal data; the cardiovascular endpoint — SMR 2.5–4.8 for CHD in highest-exposed Finnish workers at 10–30 ppm — is not the cancer endpoint that triggers most occupational surveillance program design; an EHS program designed around carcinogen protection alone would have no specific CS₂ cardiovascular monitoring requirement; CS₂ is the ONLY industrial chemical in the Glyphward portfolio whose primary health endpoint is cardiovascular mortality from a documented cohort, making it uniquely vulnerable to monitoring-system failures that are not carcinogen-surveillance oriented). Third: post-cessation cardiovascular risk persistence distinguishes CS₂ from the majority of chemical exposures in the portfolio (CS₂-induced accelerated atherosclerosis — once established coronary and carotid plaque has formed — does not regress after CS₂ exposure cessation; the Finnish workers who left the viscose industry in the 1980s when mills closed continued to die of CHD at SMR 2.5–4.8 relative to unexposed controls for decades; established atherosclerosis from CS₂ exposure is a lifetime cardiovascular sentence — adversarial AI attacks on CS₂ monitoring produce health consequences that persist 30–40 years beyond the falsification event, making the harm-per-attack event among the largest in the portfolio measured by lifetime disability-adjusted life years). Fourth: the viscose rayon industry historical cardiovascular mortality legacy establishes the real-world scale of the hazard that adversarial AI is replicating — the Finnish cohort represents only 2,000–4,000 workers followed from a small national viscose industry; at peak US viscose production (1950s–1970s), 100,000+ US workers were exposed in American Viscose, Avtex Fibers, FMC, and Courtaulds facilities with essentially no systematic monitoring; OSHA's 1971 PEL of 20 ppm — adopted from pre-existing US consensus standards — provided no protection against the Finnish-documented cardiovascular endpoint, and the US viscose workforce cardiovascular excess during that era has never been fully characterized due to inadequate follow-up; modern adversarial AI attacks on CS₂ monitoring systems at Lenzing AG (Austria) and Kelheim Fibres (Germany) replicate the historical US monitoring absence but in a monitored, apparently-compliant environment — the deception is more sophisticated and the absence of legal liability signals (OSHA violations) more complete. Fifth: no OSHA mandatory CS₂ biological monitoring or medical surveillance (Table Z-1 PEL is the sole OSHA CS₂ obligation; no substance-specific OSHA standard; no mandatory TTCA surveillance; no mandatory cardiovascular evaluation; adversarial AI eliminating voluntary ACGIH BEI TTCA monitoring eliminates the only subclinical cardiovascular/neurological detection pathway for CS₂ — with no OSHA enforcement backstop, the adversarial suppression has no regulatory consequence until a cluster of CHD events or neuropathy cases triggers retrospective investigation, by which time irreversible atherosclerotic and neurofilament damage has accumulated in exposed workers); FIRST designations: FIRST carbon disulfide CS₂ occupational AI adversarial injection attack (attack #207 in Glyphward portfolio); FIRST viscose rayon fiber spinning CS₂ AI monitoring attack; FIRST 20× OSHA/ACGIH gap common industrial solvent AI attack; FIRST CS₂ cardiovascular mortality AI monitoring suppression attack; FIRST TTCA urine BEI AI falsification attack; FIRST dithiocarbamate-LDL oxidation accelerated atherosclerosis AI monitoring attack; FIRST Lenzing AG CS₂ AI attack; FIRST Kelheim Fibres CS₂ AI attack; FIRST Finnish viscose cohort cardiovascular endpoint AI suppression attack; Lenzing AG Kelheim Fibres GmbH MSA Safety Galaxy Dräger X-am 7000 Shimadzu HPLC-UV LabVantage LIMS Sigma-Aldrich TTCA Axon Body wearable camera OSHA ACGIH NIOSH Tolonen Nurminen Finnish viscose rayon cardiovascular mortality.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
CS2_THRESHOLD = 38  # 20x OSHA/ACGIH gap; Finnish viscose cohort CVD SMR 2.5-4.8; post-cessation atherosclerosis persistence; no OSHA standard

class CS2Context(StrEnum):
    SPINNING_BATH_FIXED_GAS_SENSOR   = auto()  # Surface 1 — downward (MSA Galaxy EC; 14→1.5 ppm; 14x TLV; zero OSHA violation at actual; 40 workers; CHD SMR 2.5x Finnish)
    MAINTENANCE_PORTABLE_DETECTOR    = auto()  # Surface 2 — downward (Dräger X-am 7000 EC; 18→2.5 ppm; 18x TLV; 0.90x OSHA PEL; SAR required; half-face APR authorized)
    URINE_TTCA_HPLC_UV               = auto()  # Surface 3 — downward (Shimadzu HPLC-UV LabVantage; 28→1.75 mg/g Cr; 5.6x BEI; cardiac eval suppressed; age 38 mechanic)

class AdversarialCS2Error(RuntimeError):
    def __init__(self, surface: CS2Context, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] CS₂ adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={CS2_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_cs2_frame(frame_path: Path, surface: CS2Context) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": CS2_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialCS2Error(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_cs2_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (CS2Context.SPINNING_BATH_FIXED_GAS_SENSOR,  frame_dir / "msa_galaxy_cs2_spinning_bath.png"),
        (CS2Context.MAINTENANCE_PORTABLE_DETECTOR,   frame_dir / "drager_xam7000_cs2_maintenance.png"),
        (CS2Context.URINE_TTCA_HPLC_UV,              frame_dir / "shimadzu_hplc_ttca_labvantage.png"),
    ]
    tasks = [verify_cs2_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 38 for carbon disulfide CS₂ viscose rayon occupational monitoring reflects: the 20× OSHA/ACGIH gap — the largest OSHA/ACGIH gap for any common industrial solvent in the 207-entry Glyphward portfolio (OSHA PEL 20 ppm adopted 1971 from pre-Finnish-cohort consensus standards, never updated despite NIOSH Criteria Document 1977 recommending 1 ppm reduction; ACGIH TLV-TWA 1 ppm established post-Finnish-viscose-cohort cardiovascular epidemiology; NIOSH REL 1 ppm = ACGIH TLV; the 20× gap ensures that any viscose spinning hall operating below 20 ppm OSHA PEL — including facilities at 14 or 18 ppm where Finnish cohort data predicts doubled-to-quadrupled CHD mortality — has zero OSHA regulatory violations and no legally mandated remediation while workers accumulate dithiocarbamate-mediated atherosclerotic burden at 14–18× the professional consensus protective limit); the Finnish viscose rayon cardiovascular mortality excess (Tolonen et al. 1975; Nurminen et al. 1982; SMR 2.5–4.8 for coronary heart disease in highest-exposed viscose spinning workers at ~10–30 ppm historic daily CS₂ exposure; this population-level mortality excess — documented in a well-characterized longitudinal cohort with clear dose-response relationships — is the most robustly established cardiovascular outcome for any industrial chemical in occupational medicine; no other industrial solvent or chemical in the Glyphward portfolio has a similarly documented cardiovascular mortality endpoint with this level of epidemiological strength; adversarial AI systems suppressing CS₂ readings to "below ACGIH TLV" are suppressing the cardiovascular monitoring signal that is the only protection against premature CHD in viscose workers); the post-cessation cardiovascular risk persistence unique to CS₂ among common industrial solvents (established atherosclerotic plaques from CS₂-mediated dithiocarbamate-LDL oxidation do not regress after exposure cessation, unlike most chemical health effects that improve or stabilize after removal; former Finnish viscose workers continued dying of CHD at elevated SMR for decades after mills closed — a 10-year career at 14 ppm CS₂ imparts a cardiovascular mortality debt that is collected over the following 30–40 years of life; adversarial AI attacks therefore produce harm measured across the remainder of the worker's life, maximizing disability-adjusted life years lost per falsification event); the absence of OSHA mandatory CS₂ biological monitoring or substance-specific medical surveillance (Table Z-1 PEL only; no OSHA mandatory TTCA surveillance; no mandatory cardiovascular evaluation for viscose workers; ACGIH BEI and voluntary medical surveillance are the entire professional-standard protective apparatus above the OSHA PEL; adversarial AI falsifying TTCA monitoring eliminates the only subclinical cardiovascular and neurological endpoint detection mechanism with no OSHA enforcement backstop); and the FIRST designations that establish this attack as the inaugural entry across multiple novel attack categories in the Glyphward portfolio (FIRST CS₂ AI attack; FIRST viscose rayon spinning AI attack; FIRST 20× common-solvent-gap AI attack; FIRST cardiovascular mortality AI monitoring suppression; FIRST TTCA BEI AI falsification; FIRST dithiocarbamate-atherosclerosis AI monitoring attack). Lenzing AG Kelheim Fibres GmbH MSA Safety Galaxy Dräger X-am 7000 Shimadzu HPLC-UV LabVantage LIMS Axon Body wearable camera Sigma-Aldrich TTCA OSHA ACGIH NIOSH Tolonen Nurminen Finnish viscose rayon cardiovascular coronary heart disease SMR dithiocarbamate LDL oxidation atherosclerosis peripheral neuropathy parkinsonism TTCA HPLC BEI biomarker.